[JPI Seminar] Ministry of Health, Labour and Welfare: "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials," to be held on Thursday, April 9
Key facts
- [JPI Seminar] Ministry of Health, Labour and Welfare: "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials," to be held on Thursday, April 9
- JPI (Japan Planning Institute) will hold a seminar featuring Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare, to discuss strategies for strengthening Japan's drug discovery capabilities and addressing the 'drug loss' issue.
- Date: March 30, 2026
Direct answer
JPI (Japan Planning Institute) will hold a seminar featuring Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare, to discuss strategies for strengthening Japan's drug discovery capabilities and addressing the 'drug loss' issue.
- Citation
- [JPI Seminar] Ministry of Health, Labour and Welfare: "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials," to be held on Thursday, April 9 (March 30, 2026)
- Source
- PR Times
- Date
- March 30, 2026
JPI (Japan Planning Institute) will hold a seminar featuring Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare, to discuss strategies for strengthening Japan's drug discovery capabilities and addressing the 'drug loss' issue.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 05:11
- 🤖 AI Analyzed: May 26, 2026 at 21:27 (1384h 15m after Published)
**Seminar Details:**
- **Title:** The Worsening 'Drug Loss' Issue and Strengthening Japan's Drug Discovery Capabilities — MHLW: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials: Regulatory Harmonization and Specific Measures for Rapid Delivery of Latest Pharmaceuticals.
- **Date & Time:** Thursday, April 9, 2026, 09:30 - 11:30 (Archive distribution available after the event).
- **Speaker:** Yasuhiro Araki, Director, Clinical Trial Promotion Office, MHLW.
- **Lecture Overview:** In recent years, the 'drug loss' problem—where drugs approved in the West are not developed in Japan—has become apparent. To address this, the public and private sectors are working together to strengthen Japan's drug discovery power, deliver the latest medicines quickly, and build a sustainable social system for investment and innovation. This lecture will provide an overview of government efforts toward building a drug discovery ecosystem and detail the current state and promotional measures for clinical trials.
- **Key Topics:**
1. Current status of drug loss in Japan.
2. Policies for building a drug discovery ecosystem.
3. Challenges in Japanese clinical trials.
4. MHLW initiatives to promote clinical trials.
5. Q&A and Networking.
FAQ
What is the main topic of the JPI seminar hosted by the Ministry of Health, Labour and Welfare?
The seminar will focus on building a drug discovery ecosystem and implementing measures to promote clinical trials in Japan, addressing the 'drug loss' issue.
Who is the speaker at the JPI seminar, and what is their role?
The speaker is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare (MHLW).
What is the 'drug loss' issue that the seminar aims to address?
The 'drug loss' issue refers to the problem where drugs approved in Western countries are not developed or made available in Japan.
When and where will the JPI seminar on drug discovery and clinical trials take place?
The seminar is scheduled for Thursday, April 9, 2026, from 09:30 to 11:30. Archive distribution will be available after the event.
What are some of the key topics that will be covered during the lecture?
Key topics include the current status of drug loss in Japan, policies for building a drug discovery ecosystem, challenges in Japanese clinical trials, and MHLW initiatives to promote clinical trials.